Trial Opportunities

General News

Akili Achieves Primary Efficacy Endpoint in Pediatric ADHD Pivotal Trial

Company Completes Large Multi-Center, Randomized, Controlled Study of Novel Digital Medicine and Plans Regulatory Filing   BOSTON, Mass – December 4, 2017 – Akili Interactive (“Akili” or “Company”), an affiliate of PureTech Health (PRTC.L), today announced top-line results from the Company’s STARS-ADHD pivotal study of its lead investigational digital medicine, AKL-T01, in pediatric attention-deficit/hyperactivity disorder (ADHD). In a randomized, […]

Summer 2016 Updates

New Clinical Trials for Summer 2016 Hello everyone! We will be starting enrollment on a few new clinical trials and will be wrapping up enrollment with others. Below is an update on the various study openings and closings. If you would like to sign up to participate, fill out a trial application or contact us […]

Help Make a Difference

Let’s start by playing a word game! I’m going to type a word and I want you to say the first word that pops into your head. Are you ready? Okay then, here we go… Alzheimer’s. What word popped into your head? Grandmother? Grandfather? Maybe it was Dad or Mom? Or maybe it was husband […]

A New Era Has Arrived

Today marks a special day for IPS Research.  Over the past 3 months, we have been working with Robot House Creative to update our logo and website to better reflect who we are and what we are about. It has been a process that has made us reflect on our identity, values, and direction as a […]

Walk to End Alzheimer’s

Our IPS team had a blast at this year’s Walk to End Alzheimer’s. It was a beautiful morning with perfect weather. The crowd was large and energetic. A big thank you to the Alzheimer’s Association and everyone who helped to organize this event. We appreciate all who came out to show support for Alzheimer’s research. […]